Peliosis hepatis in a renal transplant recipient and in a haemodialysis patient

G J Hankey, B M Saker

    Research output: Contribution to journalArticle

    9 Citations (Scopus)

    Abstract

    Peliosis hepatis is described in a renal transplant recipient and in a patient who was receiving long-term haemodialysis. This uncommon liver lesion has been reported in a number of patients, including 18 renal transplant recipients and two patients with chronic renal failure. However, its cause, clinical features, natural history and clinical significance remain to be determined. We emphasize that, although it is rare, peliosis hepatis should be considered in long-term haemodialysis and renal transplant patients who exhibit hepatomegaly and/or splenomegaly and/or disordered liver function (in particular, elevation of hepatic alkaline phosphatase levels).

    Original languageEnglish
    Pages (from-to)102-5
    Number of pages4
    JournalThe Medical journal of Australia
    Volume146
    Issue number2
    Publication statusPublished - 19 Jan 1987

    Fingerprint

    Peliosis Hepatis
    Renal Dialysis
    Kidney
    Liver
    Hepatomegaly
    Splenomegaly
    Natural History
    Chronic Kidney Failure
    Alkaline Phosphatase
    Transplants
    Transplant Recipients

    Cite this

    @article{53a58ce3b6b74ed29fc920848dd6a312,
    title = "Peliosis hepatis in a renal transplant recipient and in a haemodialysis patient",
    abstract = "Peliosis hepatis is described in a renal transplant recipient and in a patient who was receiving long-term haemodialysis. This uncommon liver lesion has been reported in a number of patients, including 18 renal transplant recipients and two patients with chronic renal failure. However, its cause, clinical features, natural history and clinical significance remain to be determined. We emphasize that, although it is rare, peliosis hepatis should be considered in long-term haemodialysis and renal transplant patients who exhibit hepatomegaly and/or splenomegaly and/or disordered liver function (in particular, elevation of hepatic alkaline phosphatase levels).",
    keywords = "Adult, Azathioprine/adverse effects, Biopsy, Humans, Immunosuppression/adverse effects, Kidney Transplantation, Liver/pathology, Liver Diseases/etiology, Male, Middle Aged, Peliosis Hepatis/etiology, Renal Dialysis, Time Factors",
    author = "Hankey, {G J} and Saker, {B M}",
    year = "1987",
    month = "1",
    day = "19",
    language = "English",
    volume = "146",
    pages = "102--5",
    journal = "Medical Journal Australia",
    issn = "0025-729X",
    publisher = "Australasian Medical Publishing Co. Ltd",
    number = "2",

    }

    Peliosis hepatis in a renal transplant recipient and in a haemodialysis patient. / Hankey, G J; Saker, B M.

    In: The Medical journal of Australia, Vol. 146, No. 2, 19.01.1987, p. 102-5.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Peliosis hepatis in a renal transplant recipient and in a haemodialysis patient

    AU - Hankey, G J

    AU - Saker, B M

    PY - 1987/1/19

    Y1 - 1987/1/19

    N2 - Peliosis hepatis is described in a renal transplant recipient and in a patient who was receiving long-term haemodialysis. This uncommon liver lesion has been reported in a number of patients, including 18 renal transplant recipients and two patients with chronic renal failure. However, its cause, clinical features, natural history and clinical significance remain to be determined. We emphasize that, although it is rare, peliosis hepatis should be considered in long-term haemodialysis and renal transplant patients who exhibit hepatomegaly and/or splenomegaly and/or disordered liver function (in particular, elevation of hepatic alkaline phosphatase levels).

    AB - Peliosis hepatis is described in a renal transplant recipient and in a patient who was receiving long-term haemodialysis. This uncommon liver lesion has been reported in a number of patients, including 18 renal transplant recipients and two patients with chronic renal failure. However, its cause, clinical features, natural history and clinical significance remain to be determined. We emphasize that, although it is rare, peliosis hepatis should be considered in long-term haemodialysis and renal transplant patients who exhibit hepatomegaly and/or splenomegaly and/or disordered liver function (in particular, elevation of hepatic alkaline phosphatase levels).

    KW - Adult

    KW - Azathioprine/adverse effects

    KW - Biopsy

    KW - Humans

    KW - Immunosuppression/adverse effects

    KW - Kidney Transplantation

    KW - Liver/pathology

    KW - Liver Diseases/etiology

    KW - Male

    KW - Middle Aged

    KW - Peliosis Hepatis/etiology

    KW - Renal Dialysis

    KW - Time Factors

    M3 - Article

    VL - 146

    SP - 102

    EP - 105

    JO - Medical Journal Australia

    JF - Medical Journal Australia

    SN - 0025-729X

    IS - 2

    ER -